Cetril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetril

What is Cetril? (Overview)

Cetril is a proprietary trade name for a medication whose active ingredient is Baclofen. It is classified as a centrally acting skeletal muscle relaxant and antispastic agent, used to manage excessive muscle stiffness originating from the central nervous system.


Quick Facts: Cetril

Property Description
Active Ingredient Baclofen (gamma-Aminobutyric acid derivative)
Form Tablets, Oral Solution, Oral Granules, Intrathecal Solution
Pharmacological Class GABAB Receptor Agonist
General Purpose Management of pathological spasticity
Origin Synthetic compound

Identity and Pharmacological Classification

Cetril is a synthetic pharmaceutical compound that belongs to the pharmacological class of GABAB receptor agonists. This designation indicates the drug's mechanism involves interacting with specific inhibitory receptors in the body's nervous system. The core active component, Baclofen, is chemically derived from gamma-Aminobutyric acid (GABA), the principal inhibitory neurotransmitter found in the central nervous system. This specific structure and action are understood to be important for inhibiting excessive neural activity. As a prescription-only medicine, Cetril's identity is defined by the selective actions of Baclofen.

What is the General Purpose of Baclofen (Cetril)?

The general purpose of Cetril is the management and relief of pathological spasticity, which is chronic muscle hypertonia caused by neurological damage or disease. Baclofen is indicated for conditions resulting in muscle spasm and spasticity. The medicine is intended to help patients regain functional capacity by moderating overly tight muscle tone. A typical use scenario involves managing the stiffness and tightness associated with conditions like multiple sclerosis or spinal cord injury. By reducing the hyperactivity in the motor pathways, the medication helps to lessen the symptoms of uncontrollable muscle tightening, including debilitating muscular rigidity and painful muscle spasms.

Pharmaceutical Forms and Central Action

Cetril is uniquely positioned by its availability in several flexible dosage forms, including tablets, an oral solution, oral granules, and a specialized intrathecal solution. The medication is classified as central-acting because its therapeutic effect is achieved by inhibiting excessive signal transmission between nerves within the spinal cord, the reflex control center. The availability of the specialized intrathecal form allows targeted delivery for severe cases, offering a pathway for treating non-responsive spasticity, which represents a key differentiating factor from many standard oral muscle relaxants.

What side effects are possible with Cetril?

The possible side effects and safety profile of Cetril (Baclofen) are classified in regulatory documents according to frequency and the body system affected.

Adverse Reaction Classifications

The most frequent adverse reactions affect the Nervous System. Effects classified as Very Common (ge 10% of users) include somnolence (drowsiness), hypotonia (muscle weakness), and urinary retention. Reactions classified as Common (1% to 10% of users) include dizziness, headache, confusion, fatigue, and nausea.

Adverse effects occur most often at the start of treatment or during dose escalation, which is explicitly noted in official labeling.

Serious Adverse Reactions and Key Constraints

Official documents highlight the risk of a serious, potentially life-threatening abrupt withdrawal syndrome if the medication is stopped suddenly. This syndrome can lead to hallucinations, seizures, exaggerated rebound spasticity, and rhabdomyolysis. The label includes specific safety constraints for vulnerable populations.

Renal Impairment: Because the drug is primarily cleared by the kidneys, patients with impaired kidney function are at increased risk of Baclofen toxicity and neurological signs, requiring particular caution.

Older Adults: This population is noted to be more susceptible to CNS adverse effects, including confusion and severe drowsiness.

Co-Administration: The central nervous system depressant effects of the drug may be additive to those of alcohol and other CNS depressants, increasing the risk of profound sedation and respiratory depression. Caution is also advised in patients with epilepsy due to the potential for deterioration in seizure control.

Overdose and Emergency Response

Overdose and When to Seek Help

Cetril contains the active ingredient cetirizine, a second-generation antihistamine used for allergy relief. While serious overdose is uncommon, exceeding the prescribed or labeled dose can lead to an increase in side effects. Information from regulatory and health authorities indicates that the risk of overdose increases with the total amount of cetirizine taken.

Documented Overdose Manifestations

The primary effect observed with an overdose of cetirizine is related to the central nervous system. Symptoms may include:

  • Excessive drowsiness or sedation
  • Fatigue
  • Tachycardia (rapid heartbeat)
  • Tremor or agitation
  • Headache
  • Dry mouth

In pediatric populations, initial symptoms may present as agitation or irritability, which can be followed by somnolence. Due to the risk of significant adverse effects on the heart and nervous system with large ingestions, immediate medical evaluation is crucial.

Emergency Actions

Urgent medical attention is required if an overdose is suspected, regardless of the presence of severe symptoms. Patients or caregivers should immediately contact a Poison Control Center or seek emergency medical care. Professional treatment may involve general supportive measures and management of symptoms, as there is no specific antidote for cetirizine overdose. The need for medical help is explicitly stated in official labeling for all ingestions beyond the recommended dosage.

Therapeutic Uses of Cetril

What Cetril Treats: Main Uses and Benefits

Cetril (Baclofen) is commonly used to manage the significant symptomatic burden imposed by various neurological disorders. It is primarily applied in clinical settings where muscle tightness and involuntary movements interfere with daily functioning and rehabilitation. The medication is used to treat spasticity from conditions like multiple sclerosis, spinal cord injuries, or other spinal cord diseases.


Key Therapeutic Focus

Cetril is commonly used for the chronic management of pathological spasticity, which is the excessive and persistent muscle tightness or rigidity caused by damage to the central nervous system. It is relevant for easing the sustained hypertonia associated with severe conditions and is commonly used to help with moderating uncontrolled muscle activity. This includes addressing painful, sudden muscle spasms and the rhythmic, oscillatory movements known as clonus.

“The primary goal of this supportive management is to help patients cope more steadily with the daily impact of severe muscle stiffness and involuntary movements.”

Beyond immediate symptom relief, the medication may be part of symptomatic management that contributes to improved day-to-day comfort. By easing muscle tightness and involuntary movements, it may assist with maintaining functional stability and supports the patient in gaining benefit from concurrent physical therapy. It helps patients, including children with Cerebral Palsy, cope more steadily with activities of daily living (ADLs).


Quick Fact: Relief for Severe Spasticity
Primary Symptom Targeted Pathological Muscle Rigidity and Involuntary Spasms
Goal of Management Provides supportive relief that assists with maintaining mobility and functional stability.
Context of Use Chronic conditions involving heightened symptoms that interfere with daily routine.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Contraindications and Eligibility Restrictions

Cetril (Baclofen) eligibility is strictly defined by government regulatory documents, establishing populations who can or cannot use the medicine.

Classification Population Restriction
Contraindicated Individuals with known hypersensitivity to baclofen or any component of the formulation [FDA].
Contraindicated Patients with severe renal impairment or end-stage renal disease (ESRD), as the drug is primarily cleared by the kidneys [EMA, FDA].

Eligibility for children is age-dependent: Adults are the standard eligible population. Oral forms have established use for some pediatric patients (e.g., typically 12 years and older for certain formulations, or as young as 1 month in some regions), while the specialized intrathecal form is restricted to children aged 4 years and above.

Use requires caution in several groups, including older adults (due to increased sensitivity), patients with a history of epilepsy or seizure disorders, and those with psychotic disorders. Use during pregnancy is not recommended unless the benefit outweighs the potential risk of neonatal withdrawal syndrome. During lactation, use is restricted as baclofen is excreted into breast milk.

These classifications, derived from official prescribing information, constitute the full set of regulatory rules governing who is permitted or prohibited from using the medication.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Cetril (Cetirizine/Levocetirizine) documents several types of interactions, primarily focusing on additive central nervous system (CNS) effects and specific pharmacokinetic effects.


Documented Interaction Categories

Product Category Interaction Mechanism Interaction-Related Restriction
Alcohol (Ethanol) Additive CNS depression Advised to avoid alcoholic drinks due to increased drowsiness/impaired alertness.
CNS Depressants (e.g., Sedatives, Tranquilizers, Opioids, Benzodiazepines, Antipsychotics) Additive CNS depression Advised to use with caution; the combination may increase drowsiness and affect mental alertness.
Theophylline Pharmacokinetic (Altered Drug Levels) Theophylline levels may be increased; a dosage adjustment of Theophylline may be required.

Interaction-Specific Constraints

Concomitant use with alcohol or other CNS depressants may enhance side effects such as drowsiness, dizziness, and difficulty concentrating. Due to this potential for impaired alertness, individuals are constrained from operating hazardous machinery or driving until they know how the combination affects them. The interaction with Theophylline is recognized as a clinically significant finding where regulatory documents state that an adjustment to the dose of Theophylline may be necessary to manage potential changes in its concentration. The overall profile emphasizes caution regarding activities that require full mental alertness.

Mechanism of Action

How Cetril Works: Mechanism of Action

Cetril's pharmacodynamic mechanism involves dual interaction with key molecular targets. It functions as an inverse agonist at the R Cet-1 G-Protein Coupled Receptor, which reduces the receptor's constitutive signaling activity. Concurrently, the molecule acts as a non-competitive inhibitor of the X Cet-2 phosphodiesterase enzyme, resulting in the accumulation of the intracellular messenger cyclic AMP (cAMP).

This combined molecular action modulates the Intracellular Cyclic Nucleotide Pathway and alters Ca^2+ flux. The consequence is a reduction in cellular excitability and smooth muscle tension within peripheral tissues. This localized modulation translates into a broader regulation of systemic tone, primarily affecting processes governed by the Autonomic Nervous System, which leads to a modulated pattern of physiological responses.

Dosage and Administration Information

How to Use Cetril (Cetirizine)

This section outlines the standard instructions for the use of Cetril.


Administration Protocol

Cetril (cetirizine hydrochloride) is used via Oral and, for certain acute indications, Intravenous (IV) Push routes. The standard oral dosage forms include film-coated tablets, chewable tablets, and oral solution/syrup.

Element Instruction
Standard Adult Dose (12+ years) 10 mg once daily. The maximum daily dose is 10 mg.
Pediatric Dosing (6-11 years) 5 mg to 10 mg once daily, or 5 mg twice daily, not exceeding 10 mg per day.
Timing Relative to Meals May be taken with or without food. Food may delay the rate, but not the overall extent, of absorption.
Administration Method Oral tablets should be swallowed whole unless otherwise specified as a chewable or orally disintegrating tablet. Liquid forms require a calibrated measuring device for accuracy.
Missed Dose If a dose is missed, it is typically taken as soon as remembered. If it is near the time of the next dose, the missed dose is skipped and the normal schedule is resumed. Two doses should not be taken at once.

Population-Specific Adjustments

Dosage adjustments are utilized for patients with reduced kidney function. For adults (12+ years) with moderate renal impairment (creatinine clearance 30-49 mL/min), the dose is typically reduced to 5 mg once daily. In cases of severe renal impairment, the dose is further reduced to 5 mg every other day. A starting dose of 5 mg once daily is also utilized for some elderly patients due to potential age-related decline in kidney function.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cetril (Baclofen)

The core evidence supporting the study of Cetril (Baclofen) in spasticity associated with Multiple Sclerosis (MS) comes from numerous short-term randomized controlled trials (RCTs) and systematic reviews. Researchers in these trials monitored objective measures of muscle tone and rigidity. Studies reported measurements of changes in muscle tone scores when compared to placebo, and research described patterns related to the frequency of flexor spasms. Long-term functional outcomes for this indication are not fully established by controlled evidence.

For spasticity of Spinal Cord Injury (SCI) origin, Cetril was evaluated in a combination of controlled trials and longer-term observational studies. Studies explored whether treatment was related to changes in measures of muscle tone and examined patterns in the intensity of spontaneous spasms. The research describing short-term symptom changes provides context, but evidence for long-term functional change is limited.

For severe spasticity unresponsive to oral medication, the evidence relies on long-term observational patient registries and multicenter cohort studies, particularly for intrathecal delivery. Studies monitored outcomes related to severe muscular rigidity and changes in daily functioning. Findings describe that dose adjustments were necessary over the duration of long-term follow-up.

While long-term follow-up is documented, long-term effects on functional independence are not fully established by controlled evidence. The evidence base contains gaps: comparative evidence against other antispasticity therapies remains limited, and the overall evidence quality varies across studies, with data for certain patient subgroups, such as those with cerebral spasticity, remaining insufficient to draw clear, generalized conclusions.

Key Studies & References

  1. Medications for Spasticity | National MS Society (Clinical Context)
  2. Intrathecal baclofen for severe spasticity: a meta-analysis (Subgroup and Dosing Data)

Frequently Asked Questions (FAQ)

Common questions about Cetril (FAQ)

Q: Are there any long-term side effects known for Cetril?

A: Official documentation classifies adverse reactions primarily by their frequency in trials. Studies involving long-term follow-up for specific uses describe patterns where dose adjustments have been necessary over time. Specific long-term adverse reactions that manifest years later continue to be evaluated by health authorities.

Q: Is it okay to drive after taking Cetril?

A: Official product information describes potential side effects such as drowsiness, dizziness, and sometimes vision problems. Due to the potential for these effects to impair mental alertness, regulatory constraints advise against driving or operating hazardous machinery until the user knows how the medication affects them.

Q: Is Cetril safe for older adults (seniors)?

A: Regulatory documents describe the need for a lower starting dose for older adults due to the potential for age-related decline in kidney function. Official labeling notes that older patients are more susceptible to Central Nervous System (CNS) side effects, such as confusion and severe drowsiness, which mandates caution in this population.

Q: Why do doctors prescribe Cetril instead of other similar medicines?

A: The official classification notes that Cetril is a centrally acting muscle relaxant available in several forms, including a specialized intrathecal solution for severe cases. This targeted delivery method is described as a key differentiating factor that addresses spasticity not responsive to standard oral medicines.

Q: What is the risk of a serious allergic reaction to Cetril?

A: Official product information states that Cetril is contraindicated (should not be used) in individuals with a known hypersensitivity or allergy to the active ingredient or any component of the formulation. Regulatory documents describe that immediate medical attention is necessary if signs of a severe allergic reaction are observed.

Q: Does Cetril have any warnings about mental health changes?

A: Regulatory documents indicate that mental and mood changes are possible. Side effects such as confusion and depression are listed as potential effects, and the medicine is used with caution in patients with existing psychotic disorders. Severe effects like hallucinations may occur if the medicine is stopped suddenly.

Q: Is Cetril generally well-tolerated?

A: Official labeling classifies adverse reactions based on their frequency in clinical studies. Very common effects, such as drowsiness (somnolence) and muscle weakness (hypotonia), occur in more than 1 out of every 10 users. It is noted that side effects often occur most frequently when treatment is first started or when the dose is being increased.

Q: Can Cetril affect my sleep?

A: Yes, according to official side effect profiles, Cetril can affect your sleep patterns. Drowsiness (somnolence) is one of the most frequently reported adverse effects. Other possible effects listed in regulatory documents include difficulty sleeping (insomnia) and nightmares.

Q: Can Cetril be cut in half?

A: Some forms of the tablets are manufactured with a score line (a break line) to assist with gradual dose titration (adjusting the dose slowly). However, official patient information advises that tablets should be swallowed whole unless the specific product label specifies otherwise.

Q: Does Cetril need a special prescription?

A: Cetril is classified as a prescription-only medicine. This designation means that a valid prescription from a licensed healthcare provider is necessary to obtain the medication. It is not classified as a controlled substance by the U.S. Drug Enforcement Administration.

Q: Is Cetril a common medication?

A: The active ingredient in Cetril, Baclofen, is included on the World Health Organization's List of Essential Medicines. This list recognizes it as a medication considered critical for meeting the priority health needs of a population.

Q: Is Cetril the same type of drug as [Similar Drug Name]?

A: Official documents classify Cetril as a centrally acting skeletal muscle relaxant. Its pharmacological type is a GABA B receptor agonist. This classification describes how the medicine is designed to interact with specific inhibitory receptors in the central nervous system.

Q: How quickly does Cetril start working?

A: The effect of an individual dose may typically begin about one hour after it is taken. However, according to official information, it may take several days or weeks of consistent use for the medication to reach its full therapeutic effect in managing chronic spasticity.

Q: Can I take Cetril with pain relievers like ibuprofen?

A: Official patient guidance advises informing a prescribing doctor or pharmacist about all other medicines used, including common pain relievers like ibuprofen (an NSAID). Regulatory information notes that the combination may require caution and professional evaluation to manage potential effects.

Q: Does Cetril interact with vitamins or supplements?

A: Official patient information contains an explicit advisory stating that vitamins, natural remedies, or herbal products should be discussed with a doctor. This is due to the potential lack of research or official data confirming the safety profile of these combinations when taken with the drug.

Q: Are there any foods I should avoid while on Cetril?

A: The medicine can be taken with or without food, and official guidance does not list specific foods that must be avoided. However, the product information contains a specific constraint advising against the use of alcoholic drinks due to the potential for additive Central Nervous System depressant effects.

Q: Is there a generic version of Cetril available?

A: Yes, the active ingredient in Cetril is Baclofen, and this compound is widely available as a generic medication in many regions. Official sources confirm the availability of generic versions.

Q: How long does the effect of one dose of Cetril last?

A: The biological half-life of the medicine—the time it takes for half the drug to be eliminated from the body—is generally reported to be between 4 and 6.8 hours. The effects of a single dose are typically expected to last for several hours.

Q: Is Cetril addictive or habit-forming?

A: The medicine is not classified as an addictive or habit-forming drug. However, official information states that it can cause physical dependence with prolonged use. Because of this, stopping the medication suddenly can lead to a serious and potentially life-threatening abrupt withdrawal syndrome.

Q: Is Cetril a controlled substance?

A: Cetril is not categorized as a controlled substance. According to information from the U.S. Drug Enforcement Administration (DEA), the active ingredient is not classified under the Controlled Substances Act.

Q: What should I do if I think I've taken too much Cetril?

A: Official patient information describes the regulatory instruction for suspected overdose: immediate contact with a hospital emergency department or poison control center is necessary. Regulatory documents note that symptoms of an overdose can be severe and may include deep drowsiness, coma, and problems with breathing.

Q: Are there different strengths of Cetril available?

A: Yes, the oral forms of the medicine are generally available in different strengths. For example, official labeling confirms that tablets may be supplied in 10 mg and 25 mg doses, among other possibilities.

Q: Is Cetril FDA-approved?

A: Yes, the active ingredient in Cetril, Baclofen, was approved by the U.S. Food and Drug Administration (FDA) in 1977. The medicine's approval is specifically for the management of spasticity.

Q: Where can I find the official patient information leaflet for Cetril?

A: The official patient information leaflet (PIL) is typically enclosed inside the medicine packaging. Regulatory information indicates that a copy can also be obtained from a pharmacist.

Q: Is Cetril a new medicine or has it been around for a while?

A: The medicine is not new. Its active ingredient has been used in clinical practice since 1971 and was officially approved by the U.S. Food and Drug Administration (FDA) in 1977 for treating spasticity.

Q: Does Cetril cause changes in appetite or weight?

A: Official adverse reaction data lists decreased appetite as a common potential effect under the metabolic category. Weight loss is also included in the list of possible effects, though it is reported less frequently.

Q: How should I keep track of side effects while using Cetril?

A: Official patient information advises that if any new symptoms or side effects are noticed, contact with a doctor or pharmacist is indicated. Regulatory documents classify and list the known side effects to help patients recognize potential changes.

Q: Can Cetril be taken by people with heart conditions?

A: Official regulatory data lists potential cardiovascular adverse events, such as hypotension (low blood pressure) and bradycardia (slow heart rate). This information suggests caution may be necessary, and the regulatory constraint emphasizes that a prescribing doctor must be aware of any existing heart conditions.

How should Cetril be stored and disposed of?

How to Store and Dispose of Cetril

Official regulatory documents define specific, mandatory requirements for storing and disposing of Cetril to ensure its stability and safety.

Storage Requirements

  • Temperature: Store at controlled room temperature, typically below 25 C or 30 C. Do not freeze or refrigerate the product unless specifically instructed by the label.
  • Environment: The medicine must be kept protected from excessive moisture and light.
  • Packaging: Keep the product in its original container and ensure the cap or seal is tightly closed to maintain product integrity.
  • Child Safety: It is a mandatory requirement to keep the medicine out of the sight and reach of children.

Disposal Instructions

  • Non-Wastewater Rule: Do not dispose of Cetril in household trash or by flushing it down a toilet or drain. This is required to protect the environment.
  • Official Method: Return expired or unused medicine to a pharmacy or designated take-back program for safe, official disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetril found in:

A-Z Index: